Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
03/16/2006 | CA2579004A1 Mercaptoamides as histone deacetylase inhibitors |
03/16/2006 | CA2578789A1 Substituted heterocyclic compounds and uses thereof |
03/15/2006 | EP1634876A2 Heterocyclic compounds for the treatment of hyperlipidemia agents |
03/15/2006 | EP1633730A1 N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
03/15/2006 | EP1633722A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
03/15/2006 | EP1633352A1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain |
03/15/2006 | EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
03/15/2006 | EP1268461B1 Process for the preparation of citalopram |
03/15/2006 | EP0997147B1 Amino acid derivatives |
03/15/2006 | CN1747965A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
03/15/2006 | CN1747943A Hetero-polycyclic compounds, and coloring matters, pigments, dyes, color-changing material compositions, and color-changing films, made by using the compounds |
03/15/2006 | CN1747942A Heterocyclic compounds useful as nurr-1 activators |
03/15/2006 | CN1747936A Substituted azole derivatives as therapeutic agents |
03/15/2006 | CN1245384C Carboxamides as fungicides in agriculture |
03/14/2006 | US7012141 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor nad acceptor dyes linked together |
03/14/2006 | US7012088 Indolone oxazolidinones and derivatives thereof |
03/09/2006 | WO2006026316A2 Prodrug substituted benzoxazoles as estrogenic agents |
03/09/2006 | WO2005063239A9 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
03/09/2006 | WO2003103598A3 Amidine derivatives for treating amyloidosis |
03/09/2006 | US20060052603 Process for preparing substituted phenoxy-acetic acids from phenols |
03/09/2006 | US20060052491 Synergistic uv absorber combination |
03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
03/09/2006 | US20060052358 Modulators of ATP-binding cassette transporters |
03/09/2006 | US20060052345 Quinazolinone compounds as calcilytics |
03/09/2006 | US20060048696 Methods of crystal precipitation |
03/09/2006 | CA2576353A1 Prodrug substituted benzoxazoles as estrogenic agents |
03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
03/08/2006 | CN1745069A Mercaptoimidazoles as CCR2 receptor antagonists |
03/08/2006 | CN1743308A Novel method for synthesizing thiamphenicol and florfenicol and its key intermediate product |
03/08/2006 | CN1244579C Synthesis of 2-oxazolidone derivate by one still process |
03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
03/07/2006 | US7009078 halogenating in the 5-position and hydroxylating in the 4-position under lactonization, replacing halogen with azide, amidating lactone, then transferring the azide to the amine group |
03/07/2006 | US7009048 Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye |
03/07/2006 | US7008958 Such as 2-bromo-6-methoxy-5-(5-oxazolyl)-1H-indole-3-carboxaldehyde for treating disorders associated with inosine monophosphate dehydrogenase (IMPDH); immunosuppressants, anti-cancer agents |
03/07/2006 | US7008636 such as 5'-Octadecyloxy-[1,1';3',1'']terphenyl-2'-yloxy acetic acid for inhibiting Protien-Tyrosine Phosphatases(PTPases) from rat liver microsomes in vitro; for treatment of associated obesity, glucose intolerance, diabetes mellitus, hypertension |
03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
03/02/2006 | US20060047123 Mercaptoamides as histone deacetylase inhibitors |
03/02/2006 | US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents |
03/02/2006 | US20060046968 Estrogen receptor modulators; each ligand potentially places the receptor in a unique and unpredictable conformation that is likely to have distinct biological activities and implications for gender related drug efficacy |
03/02/2006 | DE102004040736A1 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
03/02/2006 | DE102004039533A1 Essigsäurederivate mit Cyclohexylmethoxy-Substituenten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexylmethoxy-acetic acid derivatives having substituents, processes for their preparation and their use as medicaments |
03/02/2006 | DE102004039532A1 Cyclohexyl-methyloxy substituierte Essigsäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Cyclohexyl-methyloxy-substituted acetic acid derivatives, process for their preparation and their use as medicaments |
03/02/2006 | CA2578342A1 Method for the production of diarylcycloalkyl derivatives |
03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
03/01/2006 | CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
02/28/2006 | US7005526 Thioether derivatives |
02/28/2006 | US7005441 Fluroescence analysis; controlling transcription factors; bactericides, viricides, anticancer agents, fungicides, antiprotozoa agents |
02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
02/23/2006 | WO2006018116A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
02/23/2006 | US20060041169 Preparation of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
02/23/2006 | US20060040999 CETP inhibitors |
02/23/2006 | US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione |
02/23/2006 | US20060040979 3-Aryl-2-hydroxypropionic acid derivative I |
02/23/2006 | DE102004038403A1 Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten A process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivatives |
02/23/2006 | CA2576584A1 2 - {-3-`2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
02/23/2006 | CA2576554A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
02/23/2006 | CA2576545A1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
02/21/2006 | US7002025 Process for the preparation of citalopram |
02/21/2006 | US7002020 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
02/21/2006 | US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease |
02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
02/21/2006 | CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
02/16/2006 | WO2005082900A3 Oxazolidinone amidoximes as antibacterial agents |
02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
02/16/2006 | WO2005079378A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
02/16/2006 | US20060036096 Process for producing quinolinecarbaldehyde |
02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
02/16/2006 | CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
02/15/2006 | CN1241917C 2,5-substituted benzoxazole derivative, preparing process and uses thereof |
02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
02/14/2006 | US6998420 Oxazolidinone compounds |
02/14/2006 | US6998412 Heterocyclic compounds |
02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
02/09/2006 | WO2006014015A1 Process for production of unsaturated aminodiols |
02/09/2006 | WO2005118511A3 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
02/09/2006 | WO2005112913B1 Transthyretin stabilization |
02/09/2006 | US20060030699 Reaction product of thioctic acid and tris(aminoanilinocarbonylalkyl)methylaminocarbonylalkylamine or N,N-bis{N,N-bis(aminobenzoylaminoalkyl)aminocarbonylalkyl}aminoalkanoamide; reaction product with an oligosaccharide; immobilized on support to form sensor chip used for surface plasmon resonance |
02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
02/08/2006 | EP1622952A1 Azlactone chain transfer agents for radical polymerization |
02/08/2006 | EP1622890A2 Blockers of the quorum sensing system of gram-negative bacteria |
02/08/2006 | EP1622884A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1). |
02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
02/08/2006 | EP1622866A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
02/08/2006 | CN1732152A Phenethanolamine derivative for the treatment of respiratory diseases |